NF1 tumors harbor activated Ras/MEK/ERK, while <i>NF2</i> -SWN tumors harbor activated mechanosignaling pathways, including Hippo/YAP-TAZ/TEAD. This evidence concerns the gene NF2 and neurofibromatosis type 1.